US Broker Ratings

Haemonetics Corporation (HAE) Stock Analysis: A Medical Device Leader with a Solid Growth Trajectory

Haemonetics Corporation (NYSE: HAE) is a prominent player in the healthcare sector, specifically within the medical devices industry. With a current market capitalization of approximately $4.95..

Viking Therapeutics (VKTX) Stock Analysis: Is a 206% Upside Within Reach for This Biotech Innovator?

Viking Therapeutics, Inc. (NASDAQ: VKTX) has been capturing the attention of investors with its substantial potential upside and a promising pipeline of novel therapies targeting metabolic..

BGM Group Ltd. (BGM) Stock Analysis: Unpacking Growth Potential Amidst Recent Turbulence

BGM Group Ltd. (BGM), a prominent player in China’s healthcare sector, is currently navigating a complex landscape marked by significant volatility. With a market capitalization of..

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a 26% Potential Upside

For investors with an eye on the healthcare sector, UFP Technologies, Inc. (UFPT) presents an intriguing opportunity. This US-based medical device company, with a market cap..

Ardent Health, Inc. (ARDT) Stock Analysis: Healthcare Giant with a 20% Upside Potential

Ardent Health, Inc. (ARDT), a prominent player in the Medical Care Facilities industry, is making waves in the healthcare sector with its expansive network of hospitals..

CG Oncology (CGON) Stock Analysis: Exploring the 16.39% Potential Upside in Biotech Innovation

In the ever-evolving landscape of biotechnology, CG Oncology, Inc. (NASDAQ: CGON) stands out as a company with promising potential. With a market capitalization of $6.94 billion,..

GeneDx Holdings Corp. (WGS) Stock Analysis: Navigating a 97.83 USD Current Price Amidst a 52-Week High of 167.51 USD

GeneDx Holdings Corp. (NASDAQ: WGS), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, is creating ripples among investors with its..

Disc Medicine, Inc. (IRON) Stock Analysis: A 50% Potential Upside in the Biotech Arena

Disc Medicine, Inc. (NASDAQ: IRON) is capturing the attention of investors with its promising position in the biotechnology sector, particularly in the niche of hematologic diseases...

IDEAYA Biosciences, Inc. (IDYA): Investor Outlook on a Potential 34.8% Upside in Biotechnology

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) stands at the forefront of the biotechnology sector with its focus on precision medicine oncology. The company, headquartered in South San..

Bausch Health (BHC) Stock Analysis: A 32.98% Upside Potential Amidst Strategic Restructuring

Bausch Health Companies Inc. (NYSE: BHC) stands out in the healthcare sector with a market capitalization of $2.11 billion. Known for its diversified pharmaceutical and medical..

Zai Lab Limited (ZLAB) Stock Analysis: Navigating Potential Upside with Strong Buy Ratings and Strategic Collaborations

Zai Lab Limited (NASDAQ: ZLAB), a prominent player in the biotechnology sector, continues to capture investor attention with its strategic focus on oncology, immunology, neuroscience, and..

SS Innovations International (SSII) Stock Analysis: A 112.77% Potential Upside Opportunity in the Medical Devices Sector

SS Innovations International Inc. (SSII) is making waves in the healthcare sector, particularly within the medical devices industry. With its operations spanning across India and several..

Sotera Health Company (SHC) Stock Analysis: Exploring a 21.51% Potential Upside in the Healthcare Sector

As an investor in the burgeoning healthcare sector, Sotera Health Company (NYSE: SHC) presents a compelling opportunity. With its current market capitalization standing at $5.34 billion,..

Alphatec Holdings, Inc. (ATEC): Investor Outlook Reveals a Promising 55% Upside Potential

Alphatec Holdings, Inc. (NASDAQ: ATEC), a dynamic player in the healthcare sector, specifically within the medical devices industry, is carving a niche in the surgical treatment..

Twist Bioscience Corporation (TWST) Stock Analysis: Understanding the Market Dynamics Behind the Biotech Innovator

Twist Bioscience Corporation (NASDAQ: TWST) is making waves in the biotechnology sector with its innovative approach to synthetic DNA-based products. Headquartered in South San Francisco, California,..

Warby Parker Inc. (WRBY) Stock Analysis: Uncovering a 31% Potential Upside for Investors

Warby Parker Inc. (NYSE: WRBY) has made significant strides in the healthcare sector, specifically in the dynamic industry of medical instruments and supplies. As a pioneer..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: Exploring a Potential 127% Upside

MoonLake Immunotherapeutics (NASDAQ: MLTX), a clinical-stage biotechnology company based in Zug, Switzerland, is garnering significant attention from investors due to its promising therapeutic developments and substantial..

Veracyte, Inc. (VCYT) Stock Analysis: 40.70% Potential Upside Sparks Investor Interest

Veracyte, Inc. (NASDAQ: VCYT), a prominent player in the healthcare sector, is capturing attention with its robust diagnostics and research capabilities. Headquartered in South San Francisco,..

Organon & Co. (OGN) Stock Analysis: Navigating a Challenging Landscape with Strategic Potential

Organon & Co. (NYSE: OGN), a healthcare stalwart focusing on women’s health solutions, presents a complex yet intriguing investment proposition. The company, with a market capitalization..

NewAmsterdam Pharma (NAMS) Stock Analysis: A Biotech Growth Story with 126% Potential Upside

NewAmsterdam Pharma Company N.V. (NAMS), a Netherlands-based biotech firm, is making waves in the healthcare sector with its promising research in cardiometabolic diseases. With a market..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds